New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours... but experts fear NHS can't afford them

The UK is entering a ' cancer renaissance' with pioneering personalised vaccines to combat some of the deadliest tumours expected by 2030, say leading experts.